Recurrent Head and Neck Squamous Cell Carcinoma

Also known as: Recurrent Head and Neck Squamous Cell Cancer / Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Recurrent Squamous Cell Carcinoma of the Head and Neck / Recurrent Squamous Cell Carcinoma of the Head or Neck

DrugDrug NameDrug Description
DB00002CetuximabAn endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck.
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DrugDrug NamePhaseStatusCount
DB08916Afatinib1Withdrawn1
DB08875Cabozantinib1Recruiting1
DB00002Cetuximab1Recruiting1
DB16395Efineptakin alfa1Recruiting1
DB16479Inbakicept1Recruiting1
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Completed1
DB09035Nivolumab1Withdrawn1
DB09037Pembrolizumab1Completed1
DB09037Pembrolizumab1Recruiting2
DB09143Sonidegib1Recruiting1
DB12015Alpelisib1 / 2Terminated1
DB15387Bintrafusp alfa1 / 2Recruiting1
DB14707Cemiplimab1 / 2Recruiting1
DB00002Cetuximab1 / 2Active Not Recruiting1
DB00002Cetuximab1 / 2Terminated1
DB11714Durvalumab1 / 2Terminated1
DB15631Edodekin alfa1 / 2Active Not Recruiting1
DB15721Natural Killer Cell1 / 2Active Not Recruiting1
DB14145Nepidermin1 / 2Recruiting1
DB06132Nivolumab1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting2
DB11771Tremelimumab1 / 2Terminated1
DB08875Cabozantinib2Recruiting1
DB14776Camrelizumab2Recruiting1
DB00958Carboplatin2Active Not Recruiting1
DB00958Carboplatin2Recruiting4
DB14707Cemiplimab2Recruiting1
DB00002Cetuximab2Active Not Recruiting1
DB00002Cetuximab2Completed1
DB00002Cetuximab2Recruiting1
DB14547Chloride ion2Recruiting1
DB00515Cisplatin2Recruiting2
DB01248Docetaxel2Recruiting2
DB11952Duvelisib2Recruiting1
DB11717Epacadostat2Terminated1
DB11680Ficlatuzumab2Completed1
DB11743Ipatasertib2Recruiting1
DB09035Nivolumab2Active Not Recruiting2
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Active Not Recruiting2
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting7
DB09037Pembrolizumab2Terminated1
DB12257Platinum2Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB11595Atezolizumab2 / 3Recruiting1
DB00112Bevacizumab2 / 3Recruiting1
DB00958Carboplatin2 / 3Recruiting1
DB00002Cetuximab2 / 3Recruiting1
DB14547Chloride ion2 / 3Recruiting1
DB00515Cisplatin2 / 3Recruiting1
DB01248Docetaxel2 / 3Recruiting1
DB12257Platinum2 / 3Recruiting1